Author:
Markham Anthony,Keam Susan J.
Publisher
Springer Science and Business Media LLC
Reference27 articles.
1. Ascletis. Ascletis receives NDA approval from China FDA for Ganovo [media release]. Jun 12 2018.
http://www.ascletis.com
.
2. Ganovo® (Danoprevir sodium tablets): drug information sheet. 2018.
http://www.xinyao.com.cn/yaopin/s129139.htm#p
. Accessed 11 July 2018.
3. Gower E, Estes C, Blach S, et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. J Hepatol. 2014;61(1 Suppl):S45–57.
4. Wang H, Naghavi M, Allen C, et al. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980–2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388(10053):1459–544.
5. Gane EJ, Rouzier R, Stedman C, et al. Antiviral activity, safety, and pharmacokinetics of danoprevir/ritonavir plus PEG-IFN alfa-2a/RBV in hepatitis C patients. J Hepatol. 2011;55(5):972–9.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献